News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Arena Pharmaceuticals, Inc.
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates
February 23, 2022
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2022
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23
February 09, 2022
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 18, 2022
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 21, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Achieves Target Enrollment for Etrasimod CULTIVATE Study A
November 19, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 16, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Reports Third Quarter Financial Results and Key Program Updates
November 04, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 21, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Corporate Update on November 4
October 14, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 17, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals to Host Virtual R&D Investor Calls and Participate in Upcoming September Investor Conferences
September 02, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Reports Second Quarter Financial Results and Key Program Updates
August 05, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals to Release Second Quarter 2021 Financial Results and Provide Corporate Update on August 5
July 29, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals and Aristea Therapeutics Establish Collaboration for Development of RIST4721 for Treatment of Serious Immune-Mediated Inflammatory Diseases
July 27, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 22, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Appoints Doug Manion, M.D., F.R.C.P. (C), as Executive Vice President of Research & Development
July 19, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Steven Schoch Elected to Arena Pharmaceuticals Board of Directors
June 14, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE)
June 09, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Announces First Participant Randomized in Phase 2 Trial Evaluating Temanogrel in Coronary Microvascular Obstruction (cMVO)
June 08, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Earns "A" Rating from MSCI ESG, a Leading Rating Agency for Sustainable Investments
June 03, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Earns Prime Status from ISS ESG, a Leading Rating Agency for Sustainable Investments
May 12, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Corporate Update on May 5
April 28, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Presents Clinician and Patient Reported Outcomes Data from Phase 2b ADVISE Trial Evaluating Etrasimod in Adult Atopic Dermatitis During a Late-Breaking Session at American Academy of Dermatology VMX
April 23, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Releases Second Annual Environmental, Social and Governance (ESG) Report
April 19, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial During Late-Breaking Research Session at American Academy of Dermatology Virtual Meeting Experience
April 19, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Tickers
ARNA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.